FindTrial
Sign In

ROLE OF CLINICAL PHARMACIST IN CORONARY HEART DISEASE PATIENTS

IMPACT OF PHARMACEUTICAL CARE ON CLINICAL OUTCOMES AND QUALITY OF LIFE FOR CORONARY HEART DISEASE PATIENTS IN A TERTIARY CARE TEACHING HOSPITAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018861
Enrollment
290
Registered
2019-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I21A- Other type of myocardial infarction

Interventions

Intervention1: pharmaceutical care: Clinical pharmacist along with other healthcare professionals attend the ward rounds and clinical pharmacist will provide patient counselling on diet, lifestyle and

Sponsors

Nitte University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 18 years and above diagnosed with coronary heart disease with or without comorbidities

Exclusion criteria

Exclusion criteria: Pregnant patients. Psychiatric patients.

Design outcomes

Primary

MeasureTime frame
improvement in blood pressure, total cholesterol, blood glucose,Body mass index,medication adherenceTimepoint: 6 and 12 months—

Secondary

MeasureTime frame
Development, validation and readability of patient information leaflet.Timepoint: single.—

Countries

India

Contacts

Public ContactVinay BC

NGSM Institute of Pharmaceutical Sciences

vinaybc2014@gmail.com7975128828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026